MDRO's & Screening

Edit Answers
12345678910111213141516171819202122
Across
  1. 2. : Extended-spectrum beta-lactamase production conferring resistance to third-generation cephalosporins.
  2. 4. LIAISON : Designated role coordinating between clinical areas and infection prevention service.
  3. 6. : Vancomycin-resistant Enterococcus; environmental persistence necessitates rigorous contact precautions.
  4. 8. MAPPING : Visual/temporal linkage analysis of cases, locations, and staff interactions to infer spread.
  5. 10. AGENT : Disinfectant with activity against bacterial spores; required for C. difficile environmental control.
  6. 12. PREVALENCE SURVEY : Single-time audit of colonisation/infection rates across a unit or facility.
  7. 15. STEWARDSHIP : Systematic program optimising antimicrobial use to improve outcomes and limit resistance.
  8. 16. : Multidrug-resistant organism; often requires additional precautions per local policy.
  9. 18. TRACING : Identification and management of exposed patients/staff based on risk of transmission.
  10. 20. : Carbapenemase-producing Enterobacterales (e.g., KPC, NDM, OXA-48); high risk of transmission and limited therapies.
  11. 21. CLEAN : Thorough, standardised clean of a room after patient discharge or transfer including disinfection steps.
  12. 22. HYGIENE COMPLIANCE : Percentage adherence with moments of hand hygiene; key performance indicator for IPC.
Down
  1. 1. : Methicillin-resistant Staphylococcus aureus; decolonisation per protocol and risk assessment.
  2. 3. LISTING : Tabular record of cases with key epidemiological variables used to track outbreaks.
  3. 5. : Grouping patients with the same pathogen and using dedicated staff/equipment to reduce cross-transmission.
  4. 7. RESERVOIR : Contaminated surfaces/equipment that maintain transmission potential.
  5. 9. : Protocol-based eradication or suppression (e.g., nasal mupirocin, CHG body wash) to reduce carriage.
  6. 11. MANAGEMENT : Coordinated actions to detect, contain, and eliminate transmission; includes line listing and controls.
  7. 13. : Carbapenem-resistant Enterobacterales; umbrella term that may include CPE and non-enzyme mechanisms.
  8. 14. ASSESSMENT : Patient-, procedure-, and environment-based evaluation determining required level of precautions.
  9. 17. : Targeted swabbing/testing based on risk factors (e.g., overseas healthcare, known exposure, outbreak ward).
  10. 19. PRECAUTIONS : Gown and gloves for room entry; dedicated equipment; enhanced cleaning with focus on high-touch points.